“The agreement with Neopharm significantly promotes the marketing of our products among the target audience… in fact, by joining forces with the largest medical distributor in Israel we are gaining an important advantage over our competition.”…in fact, we’ve got a competitive advantage over the senior companies, in our joined forces with the biggest medicine distributor in Israel”.

ORI WEISS, CEO OF INTELICANNA

“Medical cannabis is a health product, and it’s a field that we are involved in. It is a market that has reached a large critical mass and has become an interest to us. Neopharm is working on the importing and exporting of consumption and distribution of products, with sales of more than a billion and a half shekels and has one thousand employees. The cannabis market is expected to continue to grow, therefore we want to be a part of it”.

TAL FURRER, HEAD BUSINESS MANAGER IN NEOPHARM GROUP

SOCIAL

© 2020 INTELICANNA CORP. ALL RIGHTS RESERVED.